Published in Atherosclerosis on March 01, 1995
Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER. Atherosclerosis (2008) 1.06
Public attitudes toward ancillary information revealed by pharmacogenetic testing under limited information conditions. Genet Med (2011) 1.06
Genetic variation at the NPC1L1 gene locus, plasma lipoproteins, and heart disease risk in the elderly. J Lipid Res (2009) 0.91
Pharmacogenetics of lipid diseases. Hum Genomics (2004) 0.85
Role of pharmacogenomics in drug discovery and development. Indian J Pharmacol (2008) 0.84
The potential applications of Apolipoprotein E in personalized medicine. Front Aging Neurosci (2014) 0.81
Genetic markers associated to dyslipidemia in HIV-infected individuals on HAART. ScientificWorldJournal (2013) 0.79
Apolipoprotein E epsilon-4 polymorphism is associated with younger age at referral to a lipidology clinic and a poorer response to lipid-lowering therapy. Lipids Health Dis (2011) 0.77
ABCA1 gene variation and heart disease risk reduction in the elderly during pravastatin treatment. Atherosclerosis (2014) 0.76
Pharmacogenetics of cardiovascular drug therapy. Clin Cases Miner Bone Metab (2009) 0.75
Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins. Int J Mol Sci (2017) 0.75
Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med (1999) 16.57
Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med (1999) 9.83
A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection. Proc Natl Acad Sci U S A (1984) 5.60
Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med (1995) 4.36
Cigarette smoking and colorectal cancer mortality in the cancer prevention study II. J Natl Cancer Inst (2000) 4.20
Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation (1998) 3.89
The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell (1996) 3.81
Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. JAMA (1996) 3.68
Deprivation payments revisited (again) BMJ (1996) 3.45
Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA (2001) 3.12
Clinical features and natural history of Beckwith-Wiedemann syndrome: presentation of 74 new cases. Clin Genet (1994) 3.04
Cell lineages of the embryo of the nematode Caenorhabditis elegans. Proc Natl Acad Sci U S A (1978) 2.95
Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin Chim Acta (1987) 2.70
Epidermal naevus in Proteus syndrome showing loss of heterozygosity for an inherited PTEN mutation. Br J Dermatol (2006) 2.63
A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62
Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med (1996) 2.49
Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein. J Hepatol (1999) 2.46
Quantification of mRNA by polymerase chain reaction (PCR) using an internal standard and a nonradioactive detection method. Methods Mol Biol (1998) 2.39
Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels. N Engl J Med (1999) 2.33
Portacaval shunt in patients with familial hypercholesterolemia. Ann Surg (1983) 2.33
Pathogenesis and management of lipoprotein disorders. N Engl J Med (1985) 2.31
Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol (2000) 2.30
Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteremia model. Infect Immun (1998) 2.29
Hydrocele of the canal of Nuck in a girl: ultrasound and MR appearance. Br J Radiol (2004) 2.26
Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups. Cancer Res (1997) 2.22
Receptor tyrosine kinase specific for the skeletal muscle lineage: expression in embryonic muscle, at the neuromuscular junction, and after injury. Neuron (1995) 2.17
Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler Thromb Vasc Biol (2000) 2.10
Increased incidence of herpes zoster in the setting of cytomegalovirus preemptive therapy after kidney transplantation. Transpl Infect Dis (2013) 2.09
Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults. Cancer Causes Control (1998) 2.04
Individual classification of mild cognitive impairment subtypes by support vector machine analysis of white matter DTI. AJNR Am J Neuroradiol (2012) 2.04
Integrating family medicine and pharmacy to advance primary care therapeutics. Clin Pharmacol Ther (2008) 2.04
Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study. Neurology (1996) 2.00
Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patients. Am J Cardiol (1984) 1.99
Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest (1986) 1.98
Dna2 of Saccharomyces cerevisiae possesses a single-stranded DNA-specific endonuclease activity that is able to act on double-stranded DNA in the presence of ATP. J Biol Chem (1998) 1.97
Aberrant methylation of donor genome in cloned bovine embryos. Nat Genet (2001) 1.94
Evidence for a gene influencing the TG/HDL-C ratio on chromosome 7q32.3-qter: a genome-wide scan in the Framingham study. Hum Mol Genet (2000) 1.94
Body mass index and colon cancer mortality in a large prospective study. Am J Epidemiol (2000) 1.91
New York City syndromic surveillance systems. MMWR Morb Mortal Wkly Rep (2004) 1.91
EBUS-TBNA in the differential diagnosis of pulmonary artery sarcoma and thromboembolism. Eur Respir J (2011) 1.90
Monounsaturated fat-rich diet prevents central body fat distribution and decreases postprandial adiponectin expression induced by a carbohydrate-rich diet in insulin-resistant subjects. Diabetes Care (2007) 1.87
Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. Am J Clin Nutr (2000) 1.87
Familial apolipoprotein E deficiency. J Clin Invest (1986) 1.87
Type III hyperlipoproteinemia associated with apolipoprotein E deficiency. Science (1981) 1.84
Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation (1992) 1.84
Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis (2001) 1.84
Treatment guidelines for isolated dissection of the superior mesenteric artery based on follow-up CT findings. Eur J Vasc Endovasc Surg (2011) 1.81
Increasing incidence of fluoroquinolone-resistant Mycobacterium tuberculosis in Mumbai, India. Int J Tuberc Lung Dis (2009) 1.76
The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol (2000) 1.74
How reliably can compact chemistry analyzers measure lipids? JAMA (1990) 1.73
Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA (1994) 1.71
Centiles for adult head circumference. Arch Dis Child (1992) 1.71
Apolipoprotein A-I gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia. N Engl J Med (1986) 1.70
A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol (1999) 1.67
Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation (1995) 1.67
Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res (1988) 1.67
Impact of body mass index on coronary heart disease risk factors in men and women. The Framingham Offspring Study. Arterioscler Thromb Vasc Biol (1996) 1.65
Lipoprotein(a)-cholesterol and coronary heart disease in the Framingham Heart Study. Clin Chem (1999) 1.64
Absence of P-selectin delays fatty streak formation in mice. J Clin Invest (1997) 1.63
Late complications following permanent pacemaker implantation or elective unit replacement. Heart (1998) 1.63
Involvement of FGF-8 in initiation, outgrowth and patterning of the vertebrate limb. Development (1996) 1.61
Direct coronary stenting versus stenting with balloon pre-dilation: immediate and follow-up results of a multicentre, prospective, randomized study. The DISCO trial. DIrect Stenting of COronary Arteries. Eur Heart J (2002) 1.61
Myelomatous effusion with poor response to chemotherapy. J Korean Med Sci (2000) 1.60
A prospective longitudinal study evaluating the usefulness of a T-cell-based assay for latent tuberculosis infection in kidney transplant recipients. Am J Transplant (2011) 1.60
Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arterioscler Thromb Vasc Biol (1996) 1.60
Accuracy and precision of analyses for total cholesterol as measured with the Reflotron cholesterol method. Clin Chem (1989) 1.60
Involvement of phosphoinositide 3-kinases in neutrophil activation and the development of acute lung injury. J Immunol (2001) 1.58
Plasma apolipoprotein A-1 absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease. Arteriosclerosis (1982) 1.57
Clinical implications of detection of Ureaplasma urealyticum in the amniotic cavity with the polymerase chain reaction. Am J Obstet Gynecol (2000) 1.57
The Clostridium cellulovorans cellulosome. Crit Rev Microbiol (1994) 1.55
Tumor necrosis factor expression in human epithelial tumor cell lines. J Clin Invest (1988) 1.53
Cellulosome and noncellulosomal cellulases of Clostridium cellulovorans. Extremophiles (1998) 1.53
Microbial invasion of the amniotic cavity with Ureaplasma urealyticum is associated with a robust host response in fetal, amniotic, and maternal compartments. Am J Obstet Gynecol (1998) 1.52
Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb (1992) 1.52
Characterization of Pasteurella multocida isolates from the nares of healthy rabbits with pneumonia. Lab Anim Sci (1978) 1.51
Distribution of ApoA-I-containing HDL subpopulations in patients with coronary heart disease. Arterioscler Thromb Vasc Biol (2000) 1.49
Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms. J Lipid Res (1987) 1.49
Determinants of DNA yield and quality from buccal cell samples collected with mouthwash. Cancer Epidemiol Biomarkers Prev (2001) 1.49
Lipoprotein apoprotein metabolism. J Lipid Res (1978) 1.48
Nasal continuous positive airway pressure in patients with COPD in acute respiratory failure. A study of the immediate effects. Chest (1993) 1.48
Prevalence of risk factors in men with premature coronary artery disease. Am J Cardiol (1991) 1.47
Activation of human post heparin lipoprotein lipase by apolipoprotein H (beta 2-glycoprotein I). Biochem Biophys Res Commun (1980) 1.46
Summary of a scientific conference on preventive nutrition: pediatrics to geriatrics. Circulation (1999) 1.46
The presence of funisitis is associated with a decreased risk for the development of neonatal respiratory distress syndrome. Placenta (2011) 1.45
Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats. Infect Immun (1997) 1.44
Photodynamic therapy in the canine prostate using motexafin lutetium. Clin Cancer Res (2001) 1.43
Reference intervals for plasma apolipoprotein A-1 determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study. Clin Chem (1996) 1.43
Toxoplasma gondii: redistribution of monoclonal antibodies on tachyzoites during host cell invasion. Exp Parasitol (1985) 1.43
Cellulose promotes extracellular assembly of Clostridium cellulovorans cellulosomes. J Bacteriol (1994) 1.43
A mutation (2314delG) in the Usher syndrome type IIA gene: high prevalence and phenotypic variation. Am J Hum Genet (1999) 1.42
Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease). Ann Intern Med (1980) 1.41
Floating-Harbor syndrome. J Med Genet (1991) 1.40
Up-regulation of caveolin attenuates epidermal growth factor signaling in senescent cells. J Biol Chem (2000) 1.40
Response to complementary and alternative medicine among family medicine and other primary care physicians in South Carolina. J S C Med Assoc (2001) 1.40
Similar splice-site mutations of the ATP7A gene lead to different phenotypes: classical Menkes disease or occipital horn syndrome. Am J Hum Genet (2000) 1.40
Diet and exercise and gemfibrozil therapy for the management of dyslipidemia: a CEN study. Clinical Experience Network. J Fam Pract (1993) 1.39
Entrapment of a folded-over introducer sheath in the iliofemoral artery: an unusual complication of PTCA guiding catheter exchange. Cathet Cardiovasc Diagn (1990) 1.39